A key ocean current in the North Atlantic Ocean is weakening to the point of total collapse due to climate change, a new study warns. Scientists say the North Atlantic Subpolar Gyre – a massive system ...
Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.02 per share a year ago.
GYRE is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of GYRE shares has decreased $0.06 since the market last closed. This is a 0.73 ...
SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a ...
The stock price didn't jump after Gyre Therapeutics, Inc. (NASDAQ:GYRE) posted decent earnings last week. We did some digging and believe investors may be worried about some underlying factors in the ...
Key Insights The considerable ownership by public companies in Gyre Therapeutics indicates that they collectively have... SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) ...
AccuWeather meteorologists are monitoring for a return in tropical development expected to take during early October following a pause from late September in tropical activity amid what has been a ...
A new study questions the coherence of the circulation in the North Atlantic Ocean, as researchers show that the Gulf Stream exists, but variations off the coast of Florida do not necessarily reach ...